Protracted anaphylaxis developed after peginterferon α-2a administration for chronic hepatitis C

作     者：Akihiko Sakatani Yoshinori Doi Takaaki Matsuda Yasutaka Sasai Naohiro Nishida Megumi Sakamoto Naoto Uenoyama Yoshiya Matsumoto Kazuo Kinoshita 

作者机构：Department of Gastroenterology and HepatologyOsaka University Graduate School of MedicineSuitaOsaka 565-0871Japan Department of GastroenterologyOtemae HospitalOsaka 540-0008Japan Department of Respiratory MedicineOtemae HospitalOsaka 540-0008Japan 

出 版 物：《World Journal of Gastroenterology》 (世界胃肠病学杂志（英文版）)

年 卷 期：2015年第21卷第9期

页      面：2826-2829页

核心收录：

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 1002[医学-临床医学] 100401[医学-流行病与卫生统计学] 10[医学] 

主　　题：Peginterferon α-2a Anaphylaxis Anaphylactic shock 

摘      要：Peginterferon is a key drug used to treat chronic viral hepatitis that is known for causing various side *** effects occurring immediately after administration include headache, nausea, and influenza-like symptoms, such as fever and joint ***, reports of anaphylactic shock are extremely *** we report a patient with protracted anaphylaxis who suffered shock symptoms after peginterferon α-2a administration for chronic hepatitis *** the patient improved temporarily with shock treatment, symptoms of anaphylaxis *** peginterferon is often administered on an outpatient basis, it is important to recognize life-threatening side effects that may develop in a protracted manner.